Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Marksans Pharma Ltd.
NSE: MARKSANS
|
BSE: 524404
|
ISIN: INE750C01026
|
Industry: Pharmaceuticals
52 week high
|
Strong Performer, Getting Expensive
277.3000
13.85
(
5.26
%)
NSE
Jul 09, 2026
15:59 PM
New 52W High today
Volume:
4.6M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Marksans Pharma Ltd.
04 Oct 2023
52 week high
277.30
5.26%
MARKSANS PHARMA LTD.
Buy:
Marksans Pharma Ltd.
by
Ventura
Target: 149
Target
Ventura
Consolidating on the back of the Teva acquisition
Number of FII/FPI investors increased from 137 to 145 in Mar 2026 qtr.
More from Marksans Pharma Ltd.
Recommended
Market closes higher on foreign fund inflows and dip buying
Trendlyne Marketwatch |
09 Jul 2026, 03:56PM
Are active mutual funds worth the extra fees? We analysed over 200 funds to find out
The Baseline |
07 Jul 2026, 07:43PM
Marksans Pharma facility receives four observations from US FDA
|
10 Apr 2017